Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2401 – 2420 of 3236

https://clinicalinfo.hiv.gov/glossary/label-use-0

Postattachment Inhibitor

https://clinicalinfo.hiv.gov/glossary/postattachment-inhibitor

Inhibidores posfijación

https://clinicalinfo.hiv.gov/glossary/postattachment-inhibitor

Shock and Kill Strategy

https://clinicalinfo.hiv.gov/glossary/shock-and-kill-strategy

Estrategia de activar y eliminar

https://clinicalinfo.hiv.gov/glossary/shock-and-kill-strategy

https://clinicalinfo.hiv.gov/glossary/stigma

https://clinicalinfo.hiv.gov/glossary/stigma

Treatment as Prevention (TasP)

https://clinicalinfo.hiv.gov/glossary/treatment-prevention-tasp

Tratamiento como Prevención (TasP)

https://clinicalinfo.hiv.gov/glossary/treatment-prevention-tasp

https://clinicalinfo.hiv.gov/contact-us

https://clinicalinfo.hiv.gov/contact-us

Coccidioidomycosis

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/coccidioidomycosis

Talaromycosis (Formerly Penicilliosis)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/talaromycosis

Human Papillomavirus Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/human-papillomavirus

Prepregnancy Counseling and Care

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/prepregnancy-counseling-and-care

Reproductive Options When One or Both Partners Have HIV

https://clinicalinfo.hiv.gov/guidelines/perinatal/prepregnancy-counseling-childbearing-age-reproductive-options-partners

Appendix B: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/appendix-b-safety-and-toxicity-individual

Non-Nucleoside Reverse Transcriptase Inhibitors

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/non-nucleoside-reverse-transcriptase-inhibitors

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/tables

Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/significant-drug-interactions